Real-world tolerance and outcomes to oxaliplatin-based adjuvant chemotherapy for stage III colon cancer - Does dose intensity matter?

被引：0
|
作者：
Yoon, Robert [1 ]
Wilkinson, Kate [1 ,2 ]
Gabriel, Gabriel [2 ,3 ]
Kaadan, Nasreen [1 ,2 ,3 ]
Roberts, Tara [2 ]
Lim, Stephanie [1 ,3 ,4 ]
Ray, Asghari [1 ]
Lee, Cheok Soon [2 ,4 ,5 ]
Chua, Wei [1 ,2 ,3 ,4 ]
Ng, Weng [1 ,2 ,3 ,4 ]
机构：
[1] South Western Sydney Local Hlth Dist, Med Oncol, Sydney, NSW, Australia
[2] Ingham Inst AppliedMed Res, Sydney, NSW, Australia
[3] Univ NSW, Sch Med, Sydney, NSW, Australia
[4] Western Sydney Univ, Sch Med, Sydney, NSW, Australia
[5] South Western Sydney Local Hlth Dist, Anat Pathol, Sydney, NSW, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
252
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [1] Real-world tolerance and outcomes of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer-Does dose intensity matter?
    Yoon, Robert
    Wilkinson, Kate
    Gabriel, Gabriel
    Kadaan, Nasreen
    Roberts, Tara
    Lim, Stephanie
    Asghari, Ray
    Lee, Cheok Soon
    Chua, Wei
    Ng, Weng
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (01) : 63 - 70
  • [2] Effect of Delay in Adjuvant Oxaliplatin-Based Chemotherapy for Stage III Colon Cancer
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel
    Kennecke, Hagen F.
    Lim, Howard J.
    Cheung, Winson Y.
    Melosky, Barbara
    Gill, Sharlene
    [J]. CLINICAL COLORECTAL CANCER, 2015, 14 (01) : 25 - 30
  • [3] Impact of delay in adjuvant oxaliplatin-based chemotherapy for stage III colon cancer.
    Peixoto, Renata D'Alpino
    Kumar, Aalok
    Speers, Caroline
    Renouf, Daniel John
    Kennecke, Hagen F.
    Lim, Howard John
    Cheung, Winson Y.
    Melosky, Barbara L.
    Gill, Sharlene
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Real-world survival outcomes associated with completion of adjuvant chemotherapy for stage III colon cancer.
    Boyle, Jemma Megan
    Kuryba, Angela
    Cowling, Thomas E.
    van der Meulen, Jan
    Fearnhead, Nicola S.
    Walker, Kate
    Braun, Michael
    Aggarwal, Ajay
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [5] Prognostic value of methylator phenotype in stage III colon cancer treated with oxaliplatin-based adjuvant chemotherapy
    Gallois, C.
    Taieb, J.
    Le Corre, D.
    Le Malicot, K.
    Tabernero, J.
    Mulot, C.
    Seitz, J-F.
    Aparicio, T.
    Folprecht, G.
    Lepage, C.
    Mini, E.
    Van Laethem, J-L.
    Emile, J. F.
    Laurent-Puig, P.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [6] Prognostic Value of Methylator Phenotype in Stage III Colon Cancer Treated with Oxaliplatin-based Adjuvant Chemotherapy
    Gallois, Claire
    Taieb, Julien
    Le Corre, Delphine
    Le Malicot, Karine
    Tabernero, Josep
    Mulot, Claire
    Seitz, Jean-Francois
    Aparicio, Thomas
    Folprecht, Gunnar
    Lepage, Come
    Mini, Enrico
    Van Laethem, Jean-Luc
    Emile, Jean-Francois
    Laurent-Puig, Pierre
    [J]. CLINICAL CANCER RESEARCH, 2018, 24 (19) : 4745 - 4753
  • [7] Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis
    Huang, Wen-Kuan
    Hsu, Hung-Chih
    Chang, Shu-Hao
    Chou, Wen-Chi
    Chang, Pei-Hung
    Chiang, Sum-Fu
    Chang, John Wen-Cheng
    Chen, Jen-Shi
    Yang, Tsai-Sheng
    See, Lai-Chu
    [J]. FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [8] Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study
    Boyle, Jemma M.
    Kuryba, Angela
    Cowling, Thomas E.
    van der Meulen, Jan
    Fearnhead, Nicola S.
    Walker, Kate
    Braun, Michael S.
    Aggarwal, Ajay
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (02) : 335 - 346
  • [9] Splenomegaly in Colon Cancer During Adjuvant Oxaliplatin-based Chemotherapy
    Eren, Tulay
    Pasaoglu, Lale
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [10] Adjuvant Chemotherapy for Stage III Colon Cancer: Does Timing Matter?
    Czaykowski, Piotr M.
    Gill, Sharlene
    Kennecke, Hagen F.
    Gordon, Vallerie L.
    Turner, Donna
    [J]. DISEASES OF THE COLON & RECTUM, 2011, 54 (09) : 1082 - 1089
12345